Last updated on September 2020

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus


Brief description of study

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).

Clinical Study Identifier: NCT03616912

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.